U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
185041185041An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)CompletedNo Results AvailableObesity and Obesity-related Medical ConditionsDrug: taranabanthttps://ClinicalTrials.gov/show/NCT00131430
185042185042Ready to Use Therapeutic Food in the Rehabilitation of Severely Malnourished ChildrenActive, not recruitingNo Results AvailableMalnutritionDrug: ready-to-use therapeutic foodhttps://ClinicalTrials.gov/show/NCT00131417
185043185043A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)TerminatedNo Results AvailableObesityDrug: taranabant|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00131404
185044185044A Study of MK0364 in Obese Patients (0364-014)TerminatedNo Results AvailableObesityDrug: Comparator: taranabant|Drug: Comparator: placebohttps://ClinicalTrials.gov/show/NCT00131391
185045185045Growth Hormone, Cardiovascular Risk, and Visceral AdiposityCompletedHas ResultsObesityDrug: Nutropin AQ growth hormone|Drug: Placebo Growth Hormonehttps://ClinicalTrials.gov/show/NCT00131378
185046185046Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine FibroidsCompletedNo Results AvailableLeiomyomaDevice: ExAblate 2000https://ClinicalTrials.gov/show/NCT00131365
185047185047A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the KneeCompletedHas ResultsOsteoarthritis, Knee|Musculoskeletal DiseasesDevice: hylan G-F 20|Other: Phosphate Buffered Salinehttps://ClinicalTrials.gov/show/NCT00131352
185048185048Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic DisorderCompletedNo Results AvailablePanic DisorderBehavioral: Cognitive behavioral therapy|Drug: D-cycloserinehttps://ClinicalTrials.gov/show/NCT00131339
185049185049A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the HipCompletedNo Results AvailableOsteoarthritis, Hip|Musculoskeletal DiseasesDevice: Synvisc (hylan G-F 20)https://ClinicalTrials.gov/show/NCT00131326
185050185050Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.RecruitingNo Results AvailableChronic Lymphocytic LeukemiaDrug: Nipent, Cytoxan, Rituxanhttps://ClinicalTrials.gov/show/NCT00131313
185051185051A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder OsteoarthritisCompletedNo Results AvailableOsteoarthritis|Musculoskeletal DiseasesDevice: Synvisc (hylan G-F 20)https://ClinicalTrials.gov/show/NCT00131300
185052185052The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)CompletedNo Results AvailableDiabetes Mellitus, Type IIDrug: Extract of Agaricus blazei Murillhttps://ClinicalTrials.gov/show/NCT00131287
185053185053Gleevec Idiopathic Pulmonary Fibrosis (IPF) StudyCompletedNo Results AvailableIdiopathic Pulmonary Fibrosis|Lung Disease|Pulmonary FibrosisDrug: Imatinib Mesylate (Gleevec)https://ClinicalTrials.gov/show/NCT00131274
185054185054Clinical Trial of PXD101 in Patients With Advanced Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: PXD101|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00131261
185055185055Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm InfantsCompletedHas ResultsGastroesophageal RefluxDrug: Metaclopramide|Drug: Ranitidine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00131248
185056185056Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm BirthCompletedNo Results AvailableMalaria|Sexually Transmitted Diseases|Preterm Birth|PregnancyDrug: Sulfadoxine-pyrimethamine treatment twice during pregnancy|Drug: Sulfadoxine-pyrimethamine at 4-week intervals|Drug: Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twicehttps://ClinicalTrials.gov/show/NCT00131235
185057185057Trial to Alleviate Malnutrition With Fortified Spread Given as a Food Supplement to Underweight InfantsCompletedNo Results AvailableMalnutritionProcedure: Food supplement: fortified spread|Procedure: Food supplement: maize and soy flourhttps://ClinicalTrials.gov/show/NCT00131222
185058185058Trial to Test the Growth-Promoting Effect of Fortified Spreads When Used as Complementary Food for InfantsCompletedNo Results AvailableMalnutritionDietary Supplement: fortified spread (RUTF)|Dietary Supplement: maize and soy flourhttps://ClinicalTrials.gov/show/NCT00131209
185059185059Functional Genomic Influences on Disease Progression and Outcome in SepsisRecruitingNo Results AvailablePneumonia|Peritonitishttps://ClinicalTrials.gov/show/NCT00131196
185060185060Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable AnginaRecruitingNo Results AvailableAngina PectorisDrug: Nebidohttps://ClinicalTrials.gov/show/NCT00131183
185061185061Paravertebral Block for Breast SurgeryCompletedNo Results AvailableBreast CancerProcedure: paravertebral blockhttps://ClinicalTrials.gov/show/NCT00131170
185062185062Evaluation of Spirometry Expert Support in General PracticeActive, not recruitingNo Results AvailablePulmonary Disease, Chronic Obstructive|Asthma|Cough|DyspneaProcedure: expert support for interpretation of spirometryhttps://ClinicalTrials.gov/show/NCT00131157
185063185063Octreotide Acetate in Microspheres in Patients With Diabetic RetinopathyCompletedNo Results AvailableDiabetic RetinopathyDrug: Octreotide Acetate in Microspheres 20 mg|Drug: Octreotide Acetate in Microspheres|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00131144
185064185064Epidemiology of Gallbladder Sludge and Stones in PregnancyCompletedNo Results AvailableCholelithiasisBehavioral: exercisehttps://ClinicalTrials.gov/show/NCT00131131
185065185065Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis ImperfectaCompletedNo Results AvailableOsteogenesis ImperfectaDrug: Zoledronic Acidhttps://ClinicalTrials.gov/show/NCT00131118
185066185066The TLC2 (Teaching Healthy Lifestyles to Caregivers 2)/CALM (Counseling Advice for Lifestyle Management) StudyCompletedNo Results AvailableHealth Behavior|Psychological Stress|HealthyBehavioral: The Stanford Active Choices programhttps://ClinicalTrials.gov/show/NCT00131105
185067185067The CHAT (Community Health Advice by Telephone) StudyCompletedNo Results AvailableHealth Behavior|HealthyBehavioral: The Stanford Active Choices program|Behavioral: The TLC systemhttps://ClinicalTrials.gov/show/NCT00131092
185068185068PEPAF: Evaluation of Family Physician's Effectiveness for Physical Activity PromotionCompletedNo Results AvailableExercise|Physical Fitness|Quality of LifeBehavioral: Experimental Programme for Physical Activity Promotion|Behavioral: Controlhttps://ClinicalTrials.gov/show/NCT00131079
185069185069Long-Term Follow-Up Study of Psoriasis PatientsCompletedNo Results AvailablePsoriasisOther: Follow up from previous treatment with MEDI-507https://ClinicalTrials.gov/show/NCT00131066
185070185070Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)RecruitingNo Results AvailableLymphoblastic Leukemia, AcuteDrug: Methotrexate|Drug: Prednisolone|Drug: Dexamethasone|Drug: Vincristine|Drug: Pirarubicin|Drug: Cyclophosphamide|Drug: L-asparaginase|Drug: Cytarabine|Drug: Hydrocortisone|Drug: Mercaptopurinehttps://ClinicalTrials.gov/show/NCT00131053

* Görseller ve İçerik tekif hakkına sahip olabilir